Menu

Laurence SCHUTZ-MAIRE

SYDNEY

En résumé

Pas de description

Entreprises

  • The Kirby Institute - Clinical Project Coordinator

    2013 - maintenant
  • Abbott Laboratories - Regulatory Affairs Associate

    Rungis 2013 - 2013 Managed the preparation, submission and maintenance of registration applications of prescription medicines to the TGA and Medsafe
    - Category 3, Safety-related request and Self-assessable request Applications in Australia
    - Change Medicine Notification and Self-Assessable Change Notification in New-Zealand
    - GMP clearance
    - Maintenance and revision of Product Information, Datasheet, Consumer Medicines Information and labelling for registered products in accordance with relevant regulations
    - Liaised with internal departments locally and internationally
    - Liaised with regulatory bodies
    - Kept up to date with regulatory changes
  • Servier - Non clinical study manager

    Suresnes 2008 - 2013 Rheumatology Therapeutic Division, Suresnes, France
    •Non-clinical pharmacology studies
    - Personally responsible for external small molecule pharmacological studies, in rare diseases (drug in early development) and more common indications affecting the musculoskeletal system (drug in Phase II)
    -Worked as part of a team to select partner academic laboratories and Contract Research Organizations (CROs)
    -Led study protocol writing and reports, and interpreted study results
    -Played a central role in the coordination process between the study investigator, the CROs and international Servier’s partner
    -Submitted file to the Ethics Committee

    •Clinical studies
    -Worked as part of a team to write the pharmacokinetic part of study protocols for Phase II and Phase I Pharmacokinetic studies
    -Managed the pharmacogenetic part of a Phase II monocentric clinical trial
    -Responsible for sub-contracting the logistics of biological samples for a Phase II monocentric and Phase I Pharmacokinetic studies
    -Wrote Investigator’s Brochures
    -Fielded questions relating to a Phase II clinical trial to the Regulatory Authority

    •Project team member for 2 drugs: “Non-clinical and Kinetic Coordination”
    -Responsible for the non-clinical pharmacology development plan and the pharmacokinetics within clinical studies
    -Worked in interaction with all team members (pharmacokinetics, toxicology, pharmaceutical development, etc.)

    •Managed a 6-month trainee
  • Servier - Clinical study manager trainee

    Suresnes 2007 - 2007 Cardiovascular Therapeutic Division, Courbevoie, France
    Phase III
    - Participated in pharmacovigilance and medical review process
    - Wrote procedures, reviewed study documents

Formations

Réseau

Annuaire des membres :